Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy

<b>Background and Clinical Significance:</b> Takotsubo cardiomyopathy (TCM), an acute stress-induced left ventricular dysfunction, stems from catecholaminergic surges leading to transient myocyte stunning, calcium overload, and microvascular dysregulation. Although most cases resolve spo...

Full description

Saved in:
Bibliographic Details
Main Authors: Ajay Saraf, Amit Goyal
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Reports
Subjects:
Online Access:https://www.mdpi.com/2571-841X/8/2/43
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850165069403389952
author Ajay Saraf
Amit Goyal
author_facet Ajay Saraf
Amit Goyal
author_sort Ajay Saraf
collection DOAJ
description <b>Background and Clinical Significance:</b> Takotsubo cardiomyopathy (TCM), an acute stress-induced left ventricular dysfunction, stems from catecholaminergic surges leading to transient myocyte stunning, calcium overload, and microvascular dysregulation. Although most cases resolve spontaneously, roughly 10% deteriorate into fulminant cardiogenic shock, warranting mechanical circulatory support (MCS). Impella<sup>®</sup> provides direct transvalvular LV unloading but carries elevated risks of hemolysis, vascular compromise, and thrombogenicity. Conversely, the intra-aortic balloon pump (IABP) enhances diastolic coronary perfusion and marginally reduces afterload via counterpulsation, albeit with less potent LV decompression. Optimal MCS selection in TCM-associated shock therefore hinges on balancing hemodynamic benefits against procedural morbidity. <b>Case Presentation:</b> A 72-year-old female with coronary artery disease, paroxysmal atrial fibrillation (status post–left atrial appendage occlusion), and stage 3 chronic kidney disease presented with anterior ST-segment elevations (V2–V4) and troponin I >1000 ng/L, progressing rapidly to cardiogenic shock and respiratory failure. Coronary angiography revealed mild luminal irregularities, while echocardiography demonstrated severely reduced ejection fraction (5–10%) with characteristic apical ballooning. Refractory elevations in pulmonary capillary wedge pressure, despite escalating inotropes and vasopressors, prompted IABP insertion for partial LV offloading. Over one week, her ejection fraction improved to 35%, facilitating weaning from pressor support, extubation, and discharge on guideline-directed medical therapy. <b>Conclusions:</b> In TCM complicated by shock, meticulous MCS selection is paramount. Although Impella confers more robust unloading, heightened device-related complications may be unjustified in a largely reversible disease. IABP can sufficiently stabilize hemodynamics, enable myocardial recovery, and mitigate morbidity, underscoring the importance of individualized decision-making in TCM-related shock. Importantly, no trial has shown that MCS confers a proven long-term mortality benefit beyond initial hemodynamic rescue.
format Article
id doaj-art-ae303b8097214219a69017a6bb22d1c0
institution OA Journals
issn 2571-841X
language English
publishDate 2025-04-01
publisher MDPI AG
record_format Article
series Reports
spelling doaj-art-ae303b8097214219a69017a6bb22d1c02025-08-20T02:21:50ZengMDPI AGReports2571-841X2025-04-01824310.3390/reports8020043Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo CardiomyopathyAjay Saraf0Amit Goyal1Internal Medicine Residency, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USACardiovascular Medicine, Premier Heart Institute, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA<b>Background and Clinical Significance:</b> Takotsubo cardiomyopathy (TCM), an acute stress-induced left ventricular dysfunction, stems from catecholaminergic surges leading to transient myocyte stunning, calcium overload, and microvascular dysregulation. Although most cases resolve spontaneously, roughly 10% deteriorate into fulminant cardiogenic shock, warranting mechanical circulatory support (MCS). Impella<sup>®</sup> provides direct transvalvular LV unloading but carries elevated risks of hemolysis, vascular compromise, and thrombogenicity. Conversely, the intra-aortic balloon pump (IABP) enhances diastolic coronary perfusion and marginally reduces afterload via counterpulsation, albeit with less potent LV decompression. Optimal MCS selection in TCM-associated shock therefore hinges on balancing hemodynamic benefits against procedural morbidity. <b>Case Presentation:</b> A 72-year-old female with coronary artery disease, paroxysmal atrial fibrillation (status post–left atrial appendage occlusion), and stage 3 chronic kidney disease presented with anterior ST-segment elevations (V2–V4) and troponin I >1000 ng/L, progressing rapidly to cardiogenic shock and respiratory failure. Coronary angiography revealed mild luminal irregularities, while echocardiography demonstrated severely reduced ejection fraction (5–10%) with characteristic apical ballooning. Refractory elevations in pulmonary capillary wedge pressure, despite escalating inotropes and vasopressors, prompted IABP insertion for partial LV offloading. Over one week, her ejection fraction improved to 35%, facilitating weaning from pressor support, extubation, and discharge on guideline-directed medical therapy. <b>Conclusions:</b> In TCM complicated by shock, meticulous MCS selection is paramount. Although Impella confers more robust unloading, heightened device-related complications may be unjustified in a largely reversible disease. IABP can sufficiently stabilize hemodynamics, enable myocardial recovery, and mitigate morbidity, underscoring the importance of individualized decision-making in TCM-related shock. Importantly, no trial has shown that MCS confers a proven long-term mortality benefit beyond initial hemodynamic rescue.https://www.mdpi.com/2571-841X/8/2/43takotsubo cardiomyopathycardiogenic shockmechanical circulatory supportintra-aortic balloon pumpImpellastress-induced cardiomyopathy
spellingShingle Ajay Saraf
Amit Goyal
Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
Reports
takotsubo cardiomyopathy
cardiogenic shock
mechanical circulatory support
intra-aortic balloon pump
Impella
stress-induced cardiomyopathy
title Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
title_full Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
title_fullStr Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
title_full_unstemmed Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
title_short Shock and Awe: The Tactical Trade-Offs of Impella<sup>®</sup> Versus Intra-Aortic Balloon Pump in Takotsubo Cardiomyopathy
title_sort shock and awe the tactical trade offs of impella sup r sup versus intra aortic balloon pump in takotsubo cardiomyopathy
topic takotsubo cardiomyopathy
cardiogenic shock
mechanical circulatory support
intra-aortic balloon pump
Impella
stress-induced cardiomyopathy
url https://www.mdpi.com/2571-841X/8/2/43
work_keys_str_mv AT ajaysaraf shockandawethetacticaltradeoffsofimpellasupsupversusintraaorticballoonpumpintakotsubocardiomyopathy
AT amitgoyal shockandawethetacticaltradeoffsofimpellasupsupversusintraaorticballoonpumpintakotsubocardiomyopathy